Trials / Completed
CompletedNCT01071850
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 412 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the efficacy, safety, and tolerability of multiple doses of ASP1941 compared to placebo over 12 weeks of therapy in adult patients with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ipragliflozin | oral tablet |
| DRUG | Metformin | oral tablet |
| DRUG | Placebo | oral tablet |
Timeline
- Start date
- 2010-03-03
- Primary completion
- 2011-04-11
- Completion
- 2011-04-11
- First posted
- 2010-02-19
- Last updated
- 2025-05-22
Locations
59 sites across 5 countries: United States, Colombia, India, Mexico, Philippines
Source: ClinicalTrials.gov record NCT01071850. Inclusion in this directory is not an endorsement.